Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study

dc.authoridGARCIA-BOURNISSEN, FACUNDO/0000-0002-8732-247X
dc.authoridPoddighe, Dimitri/0000-0001-6431-9334
dc.authoridUcuncuoglu, Didar/0000-0002-2640-5976
dc.authoridDemirkaya, Erkan/0000-0003-4525-1789
dc.authoridsezer, siren/0000-0002-7326-8388
dc.authoridStenvinkel, Peter/0000-0002-8785-4820
dc.authoridhonca, tevfik/0000-0003-3723-1374
dc.authorscopusid57190093613
dc.authorscopusid13003928900
dc.authorscopusid57217041113
dc.authorscopusid6507293750
dc.authorscopusid57762018200
dc.authorscopusid6506823277
dc.authorscopusid15758674100
dc.authorwosidGARCIA-BOURNISSEN, FACUNDO/E-8286-2015
dc.authorwosidPoddighe, Dimitri/AAI-5712-2020
dc.authorwosidUcuncuoglu, Didar/B-1929-2016
dc.authorwosidDemirkaya, Erkan/F-5082-2019
dc.authorwosidsezer, siren/JYQ-2550-2024
dc.contributor.authorRomano, Micol
dc.contributor.authorGarcia-Bournissen, Facundo
dc.contributor.authorPiskin, David
dc.contributor.authorRodoplu, Ulkumen
dc.contributor.authorPiskin, Lizzy
dc.contributor.authorElzagallaai, Abdelbaset A.
dc.contributor.authorDemirkaya, Erkan
dc.date.accessioned2024-07-05T15:17:42Z
dc.date.available2024-07-05T15:17:42Z
dc.date.issued2022
dc.departmentAtılım Universityen_US
dc.department-temp[Romano, Micol; Demirkaya, Erkan] Univ Western Ontario, Schulich Sch Med & Dent, Div Paediat Rheumatol, Dept Paediat, London, ON N6A 5W9, Canada; [Romano, Micol; Piskin, David; Demirkaya, Erkan] Univ Western Ontario, Schulich Sch Med Dent, Canadian Behcet & Autoinflammatory Dis Ctr CAN BE, London, ON N6A 5W9, Canada; [Garcia-Bournissen, Facundo] Univ Western Ontario, Schulich Sch Med & Dent, Div Paediat Clin Pharmacol, Dept Paediat, London, ON N6A 5W9, Canada; [Garcia-Bournissen, Facundo; Piskin, David; Demirkaya, Erkan] Univ Western Ontario, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON N6A 3K7, Canada; [Rodoplu, Ulkumen] Emergency Med Assoc Turkey All, TR-35220 Izmir, Turkey; [Piskin, Lizzy] Univ Western Ontario, Robarts Res Inst, London, ON N6A 3K7, Canada; [Elzagallaai, Abdelbaset A.] Univ Western Ontario, Schulich Sch Med & Dent Physiol & Pharmacol, London, ON N6A 3K7, Canada; [Tuncer, Tunc] Epigenet Hlth Solut, Biochem Unit, TR-06810 Ankara, Turkey; [Sezer, Siren] Atilim Univ, Div Nephrol, Fac Med, TR-06830 Ankara, Turkey; [Ucuncuoglu, Didar] Cankiri Karatekin Univ, Dept Food Engn, Fac Engn, TR-18100 Cankiri, Turkey; [Honca, Tevfik] Gur Life Hosp, Biochem Unit, TR-26320 Eskisehir, Turkey; [Poddighe, Dimitri] Nazarbayev Univ, Dept Med, Sch Med, Nur Sultan 010000, Kazakhstan; [Poddighe, Dimitri] Univ Med Ctr, Natl Res Ctr Maternal & Child Hlth, Clin Acad, Dept Pediat, Nur Sultan 010000, Kazakhstan; [Yavuz, Izzet] Lokman Hekim Univ, Dept Nephrol, TR-06510 Ankara, Turkey; [Stenvinkel, Peter] Karolinska Univ Hosp, Karolinska Inst, Dept Renal Med 99, S-17164 Stockholm, Sweden; [Yilmaz, Mahmut Ilker] Ctr Epigenet Hlth Solut, Nephrol Unit, TR-06810 Ankara, Turkeyen_US
dc.descriptionGARCIA-BOURNISSEN, FACUNDO/0000-0002-8732-247X; Poddighe, Dimitri/0000-0001-6431-9334; Ucuncuoglu, Didar/0000-0002-2640-5976; Demirkaya, Erkan/0000-0003-4525-1789; sezer, siren/0000-0002-7326-8388; Stenvinkel, Peter/0000-0002-8785-4820; honca, tevfik/0000-0003-3723-1374en_US
dc.description.abstractWe aimed to evaluate the effect of a combination of natural products on parameters related to inflammation, endothelial dysfunction, and oxidative stress in a cohort of familial Mediterranean fever (FMF) patients with Serum Amyloid A amyloidosis, in a non-randomized, 24-week open-label interventional study. Morinda citrifolia (anti-atherosclerotic-AAL), omega-3 (anti-inflammatory-AIC), and extract with Alaskan blueberry (antioxidant-AOL) were given to patients with FMF-related biopsy-proven AA amyloidosis. Patients were >18 years and had proteinuria (>3500 mg/day) but a normal estimated glomerular filtration rate (eGFR). Arterial flow-mediated dilatation (FMD), carotid intima media thickness (CIMT), and serum biomarkers asymmetric dimethylarginine (ADMA), high sensitivity C-reactive protein (hs-CRP), pentraxin (PTX3), malondialdehyde (MDA), Cu/Zn-superoxide dismutase (Cu/Zn-SOD), and glutathione peroxidase (GSH-Px) were studied at baseline and after 24 weeks of treatment. A total of 67 FMF-related amyloidosis patients (52 male (77.6%); median age 36 years (range 21-66)) were enrolled. At the end of a 24-week treatment period with AAL, AIC, and AOL combination therapy, ADMA, MDA, PTX3, hsCRP, cholesterol, and proteinuria were significantly decreased compared to baseline, while CuZn-SOD, GSH-Px, and FMD levels were significantly increased. Changes in inflammatory markers PTX3, and hsCRP were negatively correlated with FMD change, and positively correlated with decreases in proteinuria, ADMA, MDA, cholesterol, and CIMT. Treatment with AAL, AIC and AOL combination for 24 weeks were significantly associated with reduction in inflammatory markers, improved endothelial functions, and oxidative state. Efficient control of these three mechanisms can have long term cardiovascular and renal benefits for patients with AA amyloidosis.en_US
dc.description.sponsorshipDepartment of Pediatrics, University of Western Ontario, Canadaen_US
dc.description.sponsorshipThe authors thank all the patients who took part in this study. M.R. is the recipient of matching the fund (Department of Pediatrics, University of Western Ontario, Canada) bursary for international clinical fellowship in Behcet and Autoinflammatory Disease Center.en_US
dc.identifier.citation2
dc.identifier.doi10.3390/life12060896
dc.identifier.issn2075-1729
dc.identifier.issue6en_US
dc.identifier.pmid35743929
dc.identifier.scopus2-s2.0-85132728702
dc.identifier.urihttps://doi.org/10.3390/life12060896
dc.identifier.urihttps://hdl.handle.net/20.500.14411/1775
dc.identifier.volume12en_US
dc.identifier.wosWOS:000816662000001
dc.language.isoenen_US
dc.publisherMdpien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectfamilial Mediterranean feveren_US
dc.subjectAA amyloidosisen_US
dc.subjectnatural supplementationen_US
dc.subjectendothelial dysfunctionen_US
dc.subjectoxidative stressen_US
dc.subjectinflammationen_US
dc.titleAnti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Studyen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections